A Randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND#117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (CHL) in Children and Adolescents
General Information
Age Group
Pediatrics
Status
Active
Protocol Number
AHOD1331
Offered At
Inova Children's Hospital
3300 Gallows Road
Falls Church, VA 22042
